Lecture 10: Plasmodium - resistance and susceptibility to infection Flashcards

1
Q

True or false: malaria has lead to very strong selective pressure for erythrocyte polymorphisms?

A

True (E.g. SCA and sickle-cell trait)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What causes SCA?

A

Point mutation (glutamic acid to valine at codon 6) in beta chain of haemoglobin means that under low oxygen tension, RBCs with HbS distort into sickle shapes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is sickle-cell trait?

A

heterozygous individual (one HbS allele and one Hb allele) - generally asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the relationship between the HbS allele and malaria endemicity?

A

There is a higher frequency of the HbS allele in populations where there is high malaria endemicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

True or false: HbS homozygotes are resistant to plasmodium infection?

A

True but they experience severe sickling of RBCs under normal condition and anaemia (high morbidity and mortality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is sickle-cell trait protective against plasmodium infection?

A
  1. host microRNAs post-transcriptionally regulate expression of parasite genes -abnormal transcription by the intraerythrocytic parasite (potentially affects Maurer’s cleft formation) - impair ability of parasite to present proteins like PfEMP1 on RBC surface (reduce cytoadherence and increase splenic clearance)
  2. Haemichromes (oxidised, denatureed Hb) accumulates in HbS- containing RBCs and results in formation of Bnad 3 aggregates and inhibition of knob formation resulting in increased removal of infected RBC from circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the structure of the Duffy antigen

A

Extracellular N-terminal domain with binding site for Duffy binding protein ligand (DBP)
7 transmembrane domains
Intracellular C-terminal domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which cells have the highest Duffy antigen expression?

A

Young reticulocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

For which two plasmodium species is binding to Duffy antigen particular important?

A

P. vivax

P. knowlesi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the importance of the Tyr41 amino acid?

A

It can get sulphated which is required for the high-affinity binding of BDP to the Duffy antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the purpose of the Duffy antigen (DARC)?

A

Originally identified as a blood group antigen but also expressed on endothelial cells and binds with high affinity to 11 different chemokines
- facilitates transport of chemokines across endothelium (endothelial cells)
- scavenges excess toxic chemokines (RBC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is DARC considered a silent chemokine receptor?

A

it is unable to support intracellular signaling since it lacks a G-protein motif

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we know that the function of DARC is more important on endothelial cells than RBCs?

A

Expression is conserved on endothelial cells but not on all RBCs so function on erythrocytes appears dispensable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

True or false: humans negative for the Duffy blood group antigen show some resistance to P. falciparum infection?

A

False:
- resistant to blood-stage infection with P. vivax
- interaction and reorientation but moving junction does not develop and invasion is aborted with P. knowlesi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can DARC expression be absent on erythrocytes whilst still being present on endothelial cells (null phenotype (Fy(a-b-)))?

A

the Duffy locus (FY) has two exons and an upstream promoter specific for erythroid expression
- point mutation in this erythroid promoter region within the binding site for the transcription factor (GATA-1)
- GATA-1 unable to bind to Duffy gene promoter meaning Duffy protein is absent from RBC surface and results in null ‘erythrocyte silent’ phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

True or false: DARC negative individuals are resistant to hepatic and blood-stage P.vivax infection?

A

False: only resistant to blood-stage infection but are still susceptible to hepatic-stage infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the two major co-dominant Duffy alleles and how do they differ?

A

FYA and FYB
- they differ by a single amino acid at residue 42 (Fyb = aspartic acid, Fya = glycine) - residue 42 is the last amino acid in the DBP binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why does expression of the Fy(a) DARC allele also cause reduced susceptibility to P.vivax (three theories)?

A
  1. Fyb allele encodes DARC with aspartic acid which is negatively charged and helps to coordinate binding of the positively charged PvDBP, where as the glycine of the Fy(a) DARC is neutral and does not contribute to binding to the DBP
  2. Expression of the Fy(a) allele has been seen to increased susceptbility of the Trr41 to arylsulfatase and loss of sulphate groups necessary for PvDBP binding
  3. Fy(a) individuals are more susceptible to antibody inhibition - antibodies block PvDBP binding to red blood cells
19
Q

What are Glycophorins A and B (GPA/GPB)?

A

Trans-membrane sialoglycoproteins with the N-terminus orientated outside of the RBC that carries the N-terminal MNS blood group
GPA and GPB N-terminal domains carry O-glycans
GPA also carries an N-glycan

20
Q

What contributes most of the carbohydrate present on the RBC surface?

A

GPA and GPB

21
Q

What is the consequence of the Dantu hybrid rearrangement of the GPA and GPB exons?

A

Dantu hybrid blood group rearrangement is taking some exons of GPA and GPB
- individuals expressing the Dantu blood group results in decreased ability of the antigen to be glycosylated resulting in 40% reduced risk of severe malaria in these individuals

22
Q

Why might the Dantu blood group be absent (or at very low frequency) outside of east Africa given the strong protective effective of the Dantu antigen against malaria (why is it not more widespread)?

A
  • the variant may have only recently risen (recent evolution in the human genome) so hasn’t had time to disperse

-It may only be protective against strains of P. falciparum specific to east Africa

23
Q

What are Glycophorins C and D (GPC/GPD)?

A

both products of the single GYPC gene and play an important role in maintaining the mechanical stability of erythrocytes
GPD uses an alternative methionine start codon in exon 2 so lacks exon 1 and several glycosylation sites including the N-glycan

24
Q

What is the Gerbich negative blood group?

A

deletion of exon 3 of the GYPC gene that affects the extracellular components of both GPC and GPD

25
Q

What is the effect of Gerbich negative RBCs?

A

increased resistance to P. falciparum invasion in vitro

26
Q

How does GPC mediate binding of EBA-140 ligand (a P. falciparum EBL needed for invasion)?

A

EBA-140 binding is dependent on sialic acid (requries the single N-glycan near the N-terminus (exon 1) with contributions from sialylated O-linked glycans and the GPC protein backbone)

27
Q

Why is the Gerbich phenotype associated with P. falciparum resistance when no exon 1 glycosylation sites are lost?

A

Lack of mature processing of the glycans within the golgi so the protein being expressed lacks the ability to be glycosylated in the normal way even though the protein backbone in exon 1 is unaltered - so you lose the ability to be recognised by the P. falciparum EBA-140 because no longer glycosylating and producing the recognition signal in exon 1.

28
Q

What is the Helgesson phenotype?

A

Extremely low expression of CR1 and associated Knops antigen = increased potential for host recognition as parasite no longer able to form rosettes and sequester as effectively resulting splenic clearance

29
Q

What is the Knops blood group antigen?

A

result from polymorphisms in CCP25 and CCP26 of complement receptor 1.

30
Q

Band 3 protein is associated with which blood group antigen?

A

the Diego blood group

31
Q

Describe the structure of the Band 3 protein

A

Two distinct functional domains:
- Transmembrane domain - anion exchange - responsible for gas transport and acid-base equilibrium
- cytoplasmic domain - interacts with cytoskeletal proteins (spectrin, ankyrin, proteins 4.1 and 4.2) - involved in maintenance of erythrocyte structural integrity

32
Q

What causes Southeast Asian Ovalocytosis (SAO)?

A

autosomal dominant mutation in Band 3 gene that results in an in-frame deletion that removes amino acids at the junction between the membrane transport region and the N-terminal cytoplasmic domain

33
Q

What are the effects of S. E. Asian Ovalocytosis?

A

oval shaped RBCs with:
- defective anion transport
- reduced expression of different RBC antigens
- abnormalities in morphological and mechanical properites (increased membrane rigidity)
- mild haemolytic anaemia.

34
Q

What have studies in Papua New Guinea shown about SAO and P. vivax resistance?

A

reduced risk of clinical P. vivax episodes in infants and reduced P. vivax re-infection
–> protection against P. vivax may have contributed to the heterozygote advantage of SAO observed in Papua New Guinea

35
Q

Why is SAO protective?

A
  • decrease anion transport may inhibit parasite growth
  • impaired ability of malarial parasite to develop within erythrocyte
  • stable incorporation of GPA into RBC membrane requires Band 3 protein (reduce stability of GPA may impact parasite that require GPA for RBC invasion - sialic acid dependent invasion)
  • Affect deformabiity of infected RBCs - impair transit through capillaries
36
Q

What is the relationship between glucose-6-phosphate dehydrogenase and malaria endemicity?

A

high prevalence of G6PD deficiency overlaps with regions of malaria endemicity

37
Q

what is the role of G6PD in RBCs?

A

acts as enzyme to control oxidative damage in RBCs
- works within the pentose phosphate pathway and catalyses the conversion of G6P to 6-phosphogluconate, generating NADPH
- NADPH reduces oxidised glutathione to protect RBCs against oxidative damage

38
Q

True or false: G6PD deficiency is a common human genetic condition?

A

True (many allelic variants cause different levels of enzyme deficiency)

39
Q

Which Plasmodium species is G6PD deficiency believed to confer protection against?

A

P. falciparum

40
Q

what is the significance of G6PD gene being located on the X-chromosome?

A

Females can be homozygously deficient or heterozygously deficient (who would have mixed populations of erythrocytes due to random X-inactivation)
Males are hemizygously deficient

41
Q

what types of mutations are common in G6PD deficiency and what do they cause?

A

point mutations and small deletions

cause structural defects in the enzyme
cause instability or altered activity and decreased affinity of G6PD for substrates
degraded more rapidly due to instability

42
Q

How does G6PD deficient RBCs affect plasmodium proliferation?

A

Under normal conditions, the G6PD deficient RBCs cope with low levels of available NADPH

  • infection with highly active metabolising plasmodium parasite causes damage to the red blood cell - parasite causes increase in oxidative damage (break down of Hb results in toxic by-products (particularly iron) that are a source of oxidative stress), red cell cannot cope with this due to low NADPH
  • RBC cannot be protected from the oxidative damage leading to lysis and haemolytic anaemia
  • plasmodium proliferates less efficiently
43
Q

What did a large multi-centre case-control study report about the G6PD deficiency in terms of clinical malaria outcomes?

A

Increasing levels of G6PD deficiency were associated with a decreased risk of cerebral malaria but an increased risk of severe malarial anaemia

(concluded than an evolutionary trade-off existed between different clinical outcomes of P. falciparum infection in human populations)

44
Q

ER: thalassemias and pyruvate kinase deficiency providing protection against malaria

A